Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transglutaminase 2 (TGM2) has ...
Background Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) carries high mortality. Early ...
- Reduced inflammation at the site of myocardial infarction and improved heart function demonstrated. Novel therapy to modulate immune response with apoptotic cell-derived nanovesicles. Myocardial ...
Analysis of the FOURIER trial shows that evolocumab provides greater MACE risk reduction in patients with higher BMI and stable ASCVD.
News Medical on MSN
Scientists discover a non-classical platelet mechanism linked to severe infections
Platelets are small, anucleate blood cells that play an essential role in hemostasis. Their primary task is to recognize vascular injury, become activated, and aggregate via their surface receptor ...
Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...
Objective The aim of this study was to investigate the relationship between antineutrophil cytoplasmic antibodies (ANCA) ...
Patients recently diagnosed with cancer show an increased risk for major bleeding after myocardial infarction, with the risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results